On December 31, 2015, Regeneron Pharmaceuticals (REGN) had a market capitalization of $62.6B, based on 115.66M shares at a price of $541.37.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2015 | $541.37 | 12,981,500 | 115,664,900 | $62,617,911,740.15 |
November 2015 | $543.00 | 15,062,800 | 115,664,900 | $62,805,925,035.10 |
October 2015 | $555.85 | 19,779,700 | 115,664,900 | $64,292,727,925.66 |
September 2015 | $463.86 | 20,759,500 | 115,944,000 | $53,781,517,168.80 |
August 2015 | $512.08 | 18,111,500 | 115,944,000 | $59,373,113,673.60 |
July 2015 | $552.13 | 13,328,200 | 115,944,000 | $64,016,589,712.80 |
June 2015 | $508.72 | 17,538,900 | 115,259,000 | $58,634,984,938.30 |
May 2015 | $511.15 | 15,383,600 | 115,259,000 | $58,914,292,073.00 |
April 2015 | $456.20 | 15,868,700 | 115,259,000 | $52,581,029,015.10 |
March 2015 | $450.24 | 21,053,400 | 115,183,300 | $51,859,599,148.82 |
February 2015 | $412.70 | 16,313,000 | 115,183,300 | $47,536,055,763.36 |
January 2015 | $415.51 | 17,185,100 | 115,183,300 | $47,859,974,239.62 |
December 2014 | $409.12 | 16,987,000 | 114,295,300 | $46,760,390,270.23 |
November 2014 | $414.96 | 15,016,100 | 114,295,300 | $47,428,309,144.37 |
October 2014 | $392.63 | 20,885,900 | 114,295,300 | $44,876,289,397.38 |
September 2014 | $359.53 | 16,774,200 | 117,423,000 | $42,216,633,240.30 |
August 2014 | $349.49 | 13,941,100 | 117,423,000 | $41,038,622,219.70 |
July 2014 | $315.35 | 19,959,800 | 117,423,000 | $37,029,143,430.90 |
June 2014 | $281.69 | 18,323,800 | 113,354,100 | $31,930,863,789.33 |
May 2014 | $306.11 | 15,361,600 | 113,354,100 | $34,699,254,296.58 |
April 2014 | $296.07 | 21,935,800 | 113,354,100 | $33,560,929,753.56 |
March 2014 | $299.45 | 27,725,200 | 112,151,000 | $33,583,863,682.20 |
February 2014 | $331.58 | 23,679,800 | 112,151,000 | $37,187,409,893.40 |
January 2014 | $287.79 | 19,504,800 | 112,151,000 | $32,276,429,754.40 |
December 2013 | $274.48 | 14,237,000 | 112,557,000 | $30,894,780,428.40 |
